Top

Published in:

Open Access 01-12-2022 | Correction

Correction to: Blocking circ‑SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR‑338‑3p and regulating LIN28B

Authors: Feng Qiu, Bin Qiao, Nan Zhang, Zheng Fang, Lu Feng, Shanfeng Zhang, Weiliu Qiu

Published in: Cancer Cell International | Issue 1/2022

Excerpt

In this article [1], the affiliation “The First Affiliated Hospital of Zhengzhou University” for the last corresponding author Weiliu Qiu was missing. The affiliations are corrected with this correction. …

Qiu F, Qiao B, Zhang N, Fang Z, Feng L, Zhang S, Qiu W. Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B. Cancer Cell Int. 2021;21:412. https://doi.org/10.1186/s12935-021-02110-8.CrossRefPubMedPubMedCentral

Title: Correction to: Blocking circ‑SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR‑338‑3p and regulating LIN28B
Authors: Feng Qiu
Bin Qiao
Nan Zhang
Zheng Fang
Lu Feng
Shanfeng Zhang
Weiliu Qiu
Publication date: 01-12-2022
Publisher: BioMed Central
Published in: Cancer Cell International / Issue 1/2022
Electronic ISSN: 1475-2867
DOI: https://doi.org/10.1186/s12935-022-02491-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

CARM1 promotes gastric cancer progression by regulating TFE3 mediated autophagy enhancement through the cytoplasmic AMPK-mTOR and nuclear AMPK-CARM1-TFE3 signaling pathways

Characterization of pyruvate metabolism and citric acid cycle patterns predicts response to immunotherapeutic and ferroptosis in gastric cancer

Outcome of autologous stem cell transplantation in patients with favorable-risk acute myeloid leukemia in first remission

A systematic review of anti-cancer roles and mechanisms of kaempferol as a natural compound

Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer

Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer